Electronic Component for a Drug Delivery Device
US-2024374837-A1 · Nov 14, 2024 · US
US9789259B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9789259-B2 |
| Application number | US-201113994628-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 16, 2011 |
| Priority date | Dec 21, 2010 |
| Publication date | Oct 17, 2017 |
| Grant date | Oct 17, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A dose setting mechanism for a drug delivery device is provided comprising a dose setting member and a further element. Maximum dose stop features are provided on a housing and on the further element.
Opening claim text (preview).
The invention claimed is: 1. A dose setting mechanism for a drug delivery device, the mechanism comprising: a housing comprising an internal helical thread, a dose setting member comprising an external surface that engages the internal helical thread of the housing such that the dose setting member is movable relative to the housing to set a dose, a drive sleeve which is at least partially located within the housing and which is moved along a helical path having a rotatory component and a translational component in a first axial direction relative to the housing during dose setting, a threaded piston rod in threaded engagement with the drive sleeve, wherein an inner side of the housing and a proximal flange of the drive sleeve define corresponding stops, wherein the corresponding stops are arranged to abut one another so as to limit the movement of the drive sleeve in the first axial direction during dose setting thereby defining a maximum settable dose, and wherein the dose setting member and the drive sleeve are decoupled during dose dispensing such that the dose setting member is free to rotate relative to the drive sleeve and the piston rod is free to rotate relative to the drive sleeve. 2. The dose setting mechanism according to claim 1 , wherein the housing has a first protrusion and the drive sleeve has a second protrusion and wherein the distance between the first and second protrusions defines the maximum settable dose. 3. The dose setting mechanism according to claim 1 , wherein the dose setting member and the drive sleeve are coupled during dose setting and wherein the dose setting member and the drive sleeve are rotated together during dose setting. 4. The dose setting mechanism according to claim 1 , wherein the piston rod is in direct contact with the drive sleeve. 5. The dose setting mechanism according to claim 1 , wherein the dose setting member and the piston rod are decoupled during dose dispensing such that the dose setting member and the piston rod are allowed to move relative to each other during dose dispensing. 6. The dose setting mechanism according to claim 1 , further comprising a reservoir containing a medicament, preferably insulin, which reservoir is attached to the housing.
Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic {(ampoules or carpules A61J1/06)} · CPC title
performed by axially moving actuator, e.g. an injection button · CPC title
Means preventing setting of a dose beyond the amount remaining in the cartridge · CPC title
by audible feedback · CPC title
including axial movement of dose setting member · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.